We found that elevated HELLS and decreased ICAM1 mRNA levels are predictive of poor prognoses in lung cancer patients, which could significantly improve our understanding of the causes and potential molecular events of lung cancer. The gene discussed is ICAM1; the disease is lung carcinoma.